The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC-Reference-Cited by-同舟云学术

The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC

Published:2024-03-13 Issue:6 Volume:31 Page:917-932
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Zhang Yanlong,Huang Xuefeng,Yu Minghang,Zhang Menghan,Zhao Li,Yan Yong^ORCID,Zhang Liyun,Wang Xi

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41417-024-00755-x.pdf

Reference63 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Xu P, Zhang S, Cheng J, Cao B, Huang J, Li Y, et al. Prognostic value of tumour contour irregularity on surgical strategies for T1bN0M0 renal cell carcinoma: a multi-institutional study. Eur J Radiol. 2023;159:110665.

3. Porta C, Cosmai L, Leibovich BC, Powles T, Gallieni M, Bex A. The adjuvant treatment of kidney cancer: a multidisciplinary outlook. Nat Rev Nephrol. 2019;15:423–33.

4. Grimm M-O, Bex A, De Santis M, Ljungberg B, Catto JWF, Rouprêt M, et al. Safe use of immune checkpoint inhibitors in the multidisciplinary management of urological cancer: the European Association of Urology Position in 2019. Eur Urol. 2019;76:368–80.

5. Kotecha RR, Motzer RJ, Voss MH. Towards individualized therapy for metastatic renal cell carcinoma. Nat Rev Clin Oncol. 2019;16:621–33.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of cuproptosis signature in clear cell renal cell carcinoma by single cell and spatial transcriptome analysis;Discover Oncology;2024-07-24